Maya S Eissa Selected Research

Maya S Eissa Research Topics

2	Pain (Aches) 07/2023 - 04/2023
2	Vomiting 12/2022 - 02/2021
2	Nausea 12/2022 - 02/2021
1	Acute Pain 12/2023
1	COVID-19 12/2023
1	Inflammation (Inflammations) 07/2023
1	Postoperative Pain 07/2023
1	Spasm (Spasms) 12/2022
1	Infections 03/2022
1	Premature Ejaculation 07/2021
1	Erectile Dysfunction 07/2021
1	Heart Diseases (Heart Disease) 02/2021
1	Osteoarthritis 10/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2020
1	Diabetes Mellitus 06/2020
1	Hepatitis C 08/2017

3	Celecoxib (Celebrex)FDA Link 12/2023 - 10/2020
2	Tramadol (K315)FDA LinkGeneric 12/2023 - 04/2023
2	Drug CombinationsIBA 04/2023 - 08/2017
2	doxylamine succinate FDA Link 12/2022 - 02/2021
2	Pyridoxine (Pyridoxin)FDA LinkGeneric 12/2022 - 02/2021
1	Ala(2)- enkephalinamide-Met (DAME)IBA 07/2023
1	Meloxicam (Mobic)FDA LinkGeneric 07/2023
1	Opioid Analgesics (Opioids)IBA 07/2023
1	Local AnestheticsIBA 07/2023
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 07/2023
1	AntiemeticsIBA 12/2022
1	PhloroglucinolIBA 12/2022
1	Parasympatholytics (Antispasmodics)IBA 12/2022
1	1,3,5-trimethoxybenzeneIBA 12/2022
1	SofosbuvirIBA 03/2022
1	daclatasvirIBA 03/2022
1	dapoxetineIBA 07/2021
1	Sildenafil Citrate (Viagra)FDA Link 07/2021
1	TabletsIBA 02/2021
1	Antidepressive Agents (Antidepressants)IBA 02/2021
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2020
1	mitiglinideIBA 06/2020
1	sofosbuvir drug combination ledipasvirIBA 08/2017

1	Therapeutics 09/2020